Transaction in Own Shares
Biotech Growth Ord (LON: BIOG) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Capital Markets industry, part of the Financial Services sector.
The shares were at 1348.00 GBp on 20 November 2026, up 14.2% over 52 weeks. Its 52-week range is 1148.60 GBp to 1786.00 GBp: the price is 24.5% below the high and 17.4% above the low.
At a market capitalisation of 246.74M GBP, it trades at 2.4 times trailing earnings. The median trailing P/E of its 20 largest Capital Markets peers is 15.0, a discount of 84% for BIOG.
Biotech Growth Ord reports return on equity of 46.2%.
Its Piotroski F-score is 4 out of 9, an average reading of its financial health.
No upcoming events tracked.